With the adoption of the new HTA Regulation, which aims to stimulate harmonisation of clinical assessment at EU level and reduce redundant activities in the field of health technology assessment, pharmaceutical and medical societies should rethink the way they have historically prepared for submission of HTA applications.

Download the full report here.